Ron Cami

Ron Cami is an Executive Partner at Flagship Holdings and a board member at Sail Biomedicines. Prior to this role, Ron was a Partner of the U.S. healthcare asset management platform of the B-FLEXION group (f/k/a Waypoint Group). Ron was a member of the board of directors of the B-FLEXION group, and member of its executive committee. He also oversaw the B-FLEXION group’s investment partnerships and direct holdings in the United States. Ron acted as the Group’s global general counsel and was responsible for legal, tax, compliance, and governance functions, as well as all transaction activity across the wider group.

Prior to joining B-FLEXION, Ron was a Partner and General Counsel of TPG Global in San Francisco, where he was a member of the Investment Review Committee. Ron has also served as a Partner at Cravath, Swaine & Moore and a Partner at Davis Polk & Wardwell. During his career, he has accrued deep experience in all aspects of investing and operational activities of private fund businesses and large family offices.

Ron received a B.A. at Harvard College in 1989 and J.D. from Rutgers University School of Law in 1993. Ron also clerked for Judge Kevin Thomas Duffy in U.S. District Court in New York City, while Judge Duffy presided over the first World Trade Center bombing case.